NCT05065736 2026-03-19
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
Case Comprehensive Cancer Center
University Hospital, Toulouse
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Chinese University of Hong Kong
Merck Sharp & Dohme LLC
Tagworks Pharmaceuticals BV